Document Detail

Novel oral anticoagulants for atrial fibrillation.
MedLine Citation:
PMID:  23761015     Owner:  NLM     Status:  In-Data-Review    
Three novel oral anticoagulants (NOACS)-dabigatran etexilate, rivaroxaban, and apixaban-have been approved in many countries for stroke prevention in atrial fibrillation, because they are associated with the same or lower rates of stroke, bleeding (particularly intracranially) and death compared with warfarin; and unlike warfarin, they can be given in fixed doses without routine coagulation monitoring. The effects of NOACs compared with warfarin are consistent in almost all populations and patient subgroups studied. Pharmacoeconomic analyses indicate that the NOACs are also cost-effective in Europe and North America. The lack of an antidote to the NOACs in patients who experience major bleeding has not been associated with a worse outcome among patients treated with NOACs compared with warfarin in secondary analyses. Multiple guidelines for the management of AF now recommend the NOACs for stroke prevention among atrial fibrillation (AF) patients at risk for stroke.
Graeme J Hankey; John W Eikelboom
Related Documents :
6092015 - Treatment of solitary rectal ulcer syndrome with high-fiber diet and abstention of stra...
11709515 - Frequency of clonal intraepithelial t lymphocyte proliferations in enteropathy-type int...
8260335 - Helicobacter pylori prevalence in a routine upper gastrointestinal endoscopy population.
15448425 - Adult-type hypolactasia: clinical, morphologic and functional characteristics in brazil...
11721115 - Complications and late outcome following percutaneous drainage of the gallbladder in ac...
1158035 - Red cell 2, 3-diphosphoglycerate levels among diabetic patents with and without vascula...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  15     ISSN:  1534-6242     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-06-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  344     Citation Subset:  IM    
Stroke Unit, Department of Neurology, Royal Perth Hospital, 197 Wellington Street, Perth, Australia,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Systematic review of telestroke for post-stroke care and rehabilitation.
Next Document:  11p13 deletions can be more frequent than the PAX6 gene point mutations in Polish patients with anir...